Share Information

NFL Biosciences shares are traded on Euronext Growth Paris

bt_bb_section_bottom_section_coverage_image

Share Information

Market: Euronext Growth Paris
ISIN Code: FR0014003XT0
Mnemo Code: ALNFL
Sector: Biotechnology
PEA-PME: Yes

https://www.nflbiosciences.com/wp-content/uploads/2023/06/NFL-BIOSCIENCES_ALNFL_emblem_small_colored.webp

Click the logo to see the detailed stock information on Euronext

Calendar

Events	Dates*
2025 annual results	April 15^th 2026
Annual General Meeting (Montpellier)	June 17^th 2026
2026 half-year results	October 27^th 2026

*Press releases will be published after the close of the stock market

The calendar is provided for information purposes only and may be subject to modification.

Analyst Reports (Invest Securities)

February 2, 2023

A rewarding preclinical success (french)

October 12, 2023

Visibility Q4 24, strategic review on NFL-101 (french)

September 26, 2023

PRECESTO positive, 2023 newsflow sacrificed on CESTO2 (french)

June 23, 2023

Development plan validated by EMA (french)

April 26, 2023

Financial visibility Q3 24, newsflow key element (french)

February 1st, 2023

Extended visibility thanks to AK’s success (french)

January 23, 2023

A busy year in 2023 for clinical development (french)

March 29, 2022

An acceleration of OPEX in 2022 (french)

September 17, 2021

CESTO2 now an international trial

September 6, 2021

An innovative approach to treat addiction